Received: 11 February 2022
Accepted: 1 April 2022
First Online: 6 April 2022
: The study was approved by the Norwegian Center for Research Data (NSD) (Ref. no. 163881), and the The Regional Committees for Medical and Health Research Ethics (REK) (reference no. 148193). The study was conducted in-line with guidelines in the Declaration of Helsinki [CitationRef removed]. Patients gave their written, informed consent to participate, and were informed that they could withdraw the consent at any point without any negative consequences. The data was handled confidentially and anonymous, and it is not possible to recognize individuals in the presentation of results. This is also why researchers unfamiliar with the cancer department and/or patients conducted the interviews.
: All authors declare that they have no conflicts of interest in relation to the submitted work.